Pomegranate

Pomegranate has documented blood pressure-lowering properties and can be consumed as whole seeds or as a concentrated supplement. Fresh pomegranate juice contains PON1, but the article treats this as less significant than the urolithin A pathway. Amazentis studied pomegranate by systematically breaking it down and screening pomegranate-derived compounds in aging models. Research into pomegranate health benefits initially assumed that multiple different bioactive compounds would be responsible for observed effects. Pomegranate intake alone may not produce mitochondrial and cellular benefits if urolithin A is not generated. Pomegranates contain ellagitannins and ellagic acid. A key finding from pomegranate research was that the metabolite urolithin A had a surprisingly potent mitochondrial effect. Pomegranate is positioned as an adjunct to the potassium and vitamin D combination, not as a standalone arterial remedy.